$NVCR
NovoCure Ltd

2021 Q2 Form 10-Q Financial Statement

#000164511321000092 Filed on July 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $133.5M $115.9M
YoY Change 15.18% 33.69%
Cost Of Revenue $28.60M $25.47M
YoY Change 12.27% 20.7%
Gross Profit $104.9M $90.45M
YoY Change 15.99% 37.87%
Gross Profit Margin 78.58% 78.03%
Selling, General & Admin $66.90M $53.87M
YoY Change 24.2% 19.81%
% of Gross Profit 63.76% 59.55%
Research & Development $50.32M $29.92M
YoY Change 68.18% 53.79%
% of Gross Profit 47.96% 33.08%
Depreciation & Amortization $2.480M $2.600M
YoY Change -4.62% 22.07%
% of Gross Profit 2.36% 2.87%
Operating Expenses $117.2M $83.78M
YoY Change 39.9% 30.08%
Operating Profit -$12.30M $6.668M
YoY Change -284.39% 457.53%
Interest Expense -$940.0K -$2.600M
YoY Change -63.85% 116.67%
% of Operating Profit -38.99%
Other Income/Expense, Net
YoY Change
Pretax Income -$13.24M $4.051M
YoY Change -426.71% -9520.93%
Income Tax $1.406M $2.396M
% Of Pretax Income 59.15%
Net Earnings -$14.64M $1.655M
YoY Change -984.65% -230.31%
Net Earnings / Revenue -10.97% 1.43%
Basic Earnings Per Share -$0.14 $0.02
Diluted Earnings Per Share -$0.14 $0.02
COMMON SHARES
Basic Shares Outstanding 103.5M shares 100.7M shares
Diluted Shares Outstanding 103.5M shares 107.6M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $899.0M $346.7M
YoY Change 159.31% 21.82%
Cash & Equivalents $349.1M $196.8M
Short-Term Investments $549.9M $149.9M
Other Short-Term Assets $11.46M $800.0K
YoY Change 1332.88% -61.9%
Inventory $26.69M $26.14M
Prepaid Expenses
Receivables $90.44M $76.03M
Other Receivables $17.95M $38.10M
Total Short-Term Assets $1.046B $487.8M
YoY Change 114.35% 31.84%
LONG-TERM ASSETS
Property, Plant & Equipment $11.86M $10.53M
YoY Change 12.6% 25.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.63M $4.860M
YoY Change 118.72% -14.47%
Total Long-Term Assets $51.49M $41.16M
YoY Change 25.11% 13.68%
TOTAL ASSETS
Total Short-Term Assets $1.046B $487.8M
Total Long-Term Assets $51.49M $41.16M
Total Assets $1.097B $528.9M
YoY Change 107.41% 30.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.79M $38.50M
YoY Change 47.49% 27.91%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $116.2M $85.12M
YoY Change 36.52% 15.71%
LONG-TERM LIABILITIES
Long-Term Debt $560.6M $149.5M
YoY Change 274.94% 0.11%
Other Long-Term Liabilities $173.0K $173.0K
YoY Change 0.0% -43.46%
Total Long-Term Liabilities $583.6M $176.0M
YoY Change 231.59% 1.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $116.2M $85.12M
Total Long-Term Liabilities $583.6M $176.0M
Total Liabilities $699.8M $261.1M
YoY Change 168.0% 5.59%
SHAREHOLDERS EQUITY
Retained Earnings -$646.3M -$645.3M
YoY Change 0.17% -1.8%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $397.3M $267.8M
YoY Change
Total Liabilities & Shareholders Equity $1.097B $528.9M
YoY Change 107.41% 30.22%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$14.64M $1.655M
YoY Change -984.65% -230.31%
Depreciation, Depletion And Amortization $2.480M $2.600M
YoY Change -4.62% 22.07%
Cash From Operating Activities $26.17M $12.74M
YoY Change 105.42% 40.54%
INVESTING ACTIVITIES
Capital Expenditures $2.618M $3.315M
YoY Change -21.03% 38.3%
Acquisitions
YoY Change
Other Investing Activities $2.000K $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.618M -$3.315M
YoY Change -21.03% 89.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.371M $1.667M
YoY Change 42.23% 38.0%
Debt Paid & Issued, Net $7.000K $7.000K
YoY Change 0.0% -12.5%
Cash From Financing Activities $11.06M $5.345M
YoY Change 106.9% -74.12%
NET CHANGE
Cash From Operating Activities $26.17M $12.74M
Cash From Investing Activities -$2.618M -$3.315M
Cash From Financing Activities $11.06M $5.345M
Net Change In Cash $34.61M $14.88M
YoY Change 132.59% -46.9%
FREE CASH FLOW
Cash From Operating Activities $26.17M $12.74M
Capital Expenditures $2.618M $3.315M
Free Cash Flow $23.55M $9.426M
YoY Change 149.88% 41.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001645113
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Helier
dei Entity File Number
EntityFileNumber
001-37565
dei Entity Registrant Name
EntityRegistrantName
NovoCure Limited
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Y9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1057807
dei Entity Address Address Line1
EntityAddressAddressLine1
No. 4 The Forum
dei Entity Address Address Line2
EntityAddressAddressLine2
Grenville Street
dei Entity Address Country
EntityAddressCountry
JE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
JE2 4UF
dei City Area Code
CityAreaCode
44 (0) 15
dei Local Phone Number
LocalPhoneNumber
3475 6700
dei Security12b Title
Security12bTitle
Ordinary Shares, no par value
dei Trading Symbol
TradingSymbol
NVCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103647871 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349124000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234674000 USD
CY2021Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
549907000 USD
CY2020Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
607902000 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
11463000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11499000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90436000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96699000 USD
CY2021Q2 nvcr Receivables And Prepaid Expenses
ReceivablesAndPrepaidExpenses
17946000 USD
CY2020Q4 nvcr Receivables And Prepaid Expenses
ReceivablesAndPrepaidExpenses
21245000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
26690000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
27422000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1045566000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
999441000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11857000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11395000 USD
CY2021Q2 nvcr Field Equipment Net Noncurrent
FieldEquipmentNetNoncurrent
12042000 USD
CY2020Q4 nvcr Field Equipment Net Noncurrent
FieldEquipmentNetNoncurrent
11230000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16964000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19009000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10630000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10908000 USD
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
51493000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
52542000 USD
CY2021Q2 us-gaap Assets
Assets
1097059000 USD
CY2020Q4 us-gaap Assets
Assets
1051983000 USD
CY2021Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
56785000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
53647000 USD
CY2021Q2 nvcr Other Accounts Payable Lease Liabilities And Accrued Expenses Current
OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent
59421000 USD
CY2020Q4 nvcr Other Accounts Payable Lease Liabilities And Accrued Expenses Current
OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent
59965000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
116206000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
113612000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
560562000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
429905000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8352000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
12139000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11944000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14293000 USD
CY2021Q2 nvcr Employee Related Liabilities Non Current
EmployeeRelatedLiabilitiesNonCurrent
2553000 USD
CY2020Q4 nvcr Employee Related Liabilities Non Current
EmployeeRelatedLiabilitiesNonCurrent
5171000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
173000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
337000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
583584000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
461845000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
699790000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
575457000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103641238 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103641238 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102334276 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102334276 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1044732000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1111435000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1119000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3832000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-646344000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-631077000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
397269000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
476526000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1097059000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1051983000 USD
CY2021Q2 us-gaap Revenues
Revenues
133517000 USD
CY2020Q2 us-gaap Revenues
Revenues
115925000 USD
us-gaap Revenues
Revenues
268212000 USD
us-gaap Revenues
Revenues
217753000 USD
CY2020 us-gaap Revenues
Revenues
494366000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
28599000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
25474000 USD
us-gaap Cost Of Revenue
CostOfRevenue
54984000 USD
us-gaap Cost Of Revenue
CostOfRevenue
49970000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
106501000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
104918000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
90451000 USD
us-gaap Gross Profit
GrossProfit
213228000 USD
us-gaap Gross Profit
GrossProfit
167783000 USD
CY2020 us-gaap Gross Profit
GrossProfit
387865000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50315000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29918000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96231000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55190000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
132010000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34138000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28461000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
65495000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
57294000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
118017000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32760000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25404000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63885000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52012000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107437000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
117213000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
83783000 USD
us-gaap Operating Expenses
OperatingExpenses
225611000 USD
us-gaap Operating Expenses
OperatingExpenses
164496000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
357464000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12295000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6668000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-12383000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3287000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
30401000 USD
CY2021Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
940000 USD
CY2020Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
2617000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
3586000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
5049000 USD
CY2020 us-gaap Interest And Debt Expense
InterestAndDebtExpense
12299000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13235000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4051000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1706000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15969000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1762000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18102000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1406000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2396000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7369000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14641000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18769000 USD
us-gaap Net Income Loss
NetIncomeLoss
5607000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
19808000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103484866 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100718893 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103061557 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100298230 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100930866 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103484866 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107647802 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103061557 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107897907 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108877648 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14641000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18769000 USD
us-gaap Net Income Loss
NetIncomeLoss
5607000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
19808000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
413000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
84000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
145000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-117000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-85000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-416000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-13000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2568000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
648000 USD
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
980000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13812000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1752000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16056000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4842000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18743000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
476526000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18863000 USD
CY2021Q1 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
7961000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1884000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4128000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
372134000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27881000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2371000 USD
CY2021Q2 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
8695000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
829000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14641000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
397269000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
217790000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16557000 USD
CY2020Q1 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
4511000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-862000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
3952000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
241948000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18770000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1667000 USD
CY2020Q2 nvcr Stock Issued During Period Value Stock Options And Warrants Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercisedAndRestrictedStockAwardForfeitures
3685000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
97000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1655000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
267822000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14641000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18769000 USD
us-gaap Net Income Loss
NetIncomeLoss
5607000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
19808000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2480000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2601000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4850000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4489000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9150000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
178000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
133000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
354000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
139000 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
429000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
27881000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
18770000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
46744000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
35327000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
75721000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-372000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
463000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2529000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
470000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
699000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3026000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6160000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7649000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25878000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30354000 USD
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
925000 USD
CY2020Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-538000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1528000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-1078000 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3260000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1663000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3539000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-367000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2391000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2935000 USD
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1584000 USD
CY2020Q2 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1143000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3016000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2379000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1366000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5122000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
405000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2496000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1934000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25470000 USD
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2418000 USD
CY2020Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1266000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-6812000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1492000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
664000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26172000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12741000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43952000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14698000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
99148000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2618000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3315000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6599000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6427000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14968000 USD
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 USD
CY2020Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
608000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 USD
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
150000000 USD
CY2021Q2 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 USD
CY2020Q2 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
549848000 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 USD
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
607879000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2618000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3315000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51553000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6427000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-472847000 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2371000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1667000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2371000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1667000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3370000 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
558439000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-105000 USD
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15000 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
150028000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8695000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3685000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16656000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8196000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28428000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11059000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5345000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19014000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9848000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
440209000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34610000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14880000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
114414000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18169000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66757000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325977000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182705000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246173000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179416000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179416000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
360587000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197585000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
360587000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197585000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
949000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246173000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2490000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4728000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
85000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6937000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-3261000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
1000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
3415000 USD
us-gaap Interest Paid Net
InterestPaidNet
2000 USD
us-gaap Interest Paid Net
InterestPaidNet
6831000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
8686000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
665000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1391000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2174000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5617000 USD
CY2021Q2 us-gaap Cash
Cash
33303000 USD
CY2020Q4 us-gaap Cash
Cash
20339000 USD
CY2021Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
315821000 USD
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
214335000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
349124000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234674000 USD
CY2021Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
549907000 USD
CY2020Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
607902000 USD
CY2021Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
549921000 USD
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
607905000 USD
CY2021Q2 us-gaap Deposits Assets
DepositsAssets
1418000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2333000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5175000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8106000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4896000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16251000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17351000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
26690000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
27422000 USD
CY2020Q4 us-gaap Contractual Obligation
ContractualObligation
1687000 USD
CY2020Q4 us-gaap Deposits Assets
DepositsAssets
1438000 USD
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
1750000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9220326 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
386909 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
154.71
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
798511 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
88627 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
58.14
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35327000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8720097 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.09
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5101756 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
18.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
798511 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27881000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18770000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46744000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75721000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-14641000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1655000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18769000 USD
us-gaap Net Income Loss
NetIncomeLoss
5607000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
19808000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103484866 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100718893 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103061557 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100298230 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100930866 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103484866 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107647802 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103061557 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107897907 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108877648 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9098788 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1148420 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9363037 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
598533 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1307762 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q2 us-gaap Noncurrent Assets
NoncurrentAssets
23899000 USD
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
22625000 USD
CY2021Q2 us-gaap Revenues
Revenues
133517000 USD
CY2020Q2 us-gaap Revenues
Revenues
115925000 USD
us-gaap Revenues
Revenues
268212000 USD
us-gaap Revenues
Revenues
217753000 USD
CY2020 us-gaap Revenues
Revenues
494366000 USD

Files In Submission

Name View Source Status
0001645113-21-000092-index-headers.html Edgar Link pending
0001645113-21-000092-index.html Edgar Link pending
0001645113-21-000092.txt Edgar Link pending
0001645113-21-000092-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvcr-20210630.htm Edgar Link pending
nvcr-20210630.xsd Edgar Link pending
nvcr-20210630xexx311.htm Edgar Link pending
nvcr-20210630xexx312.htm Edgar Link pending
nvcr-20210630xexx321.htm Edgar Link pending
nvcr-20210630xexx322.htm Edgar Link pending
nvcr-20210630_cal.xml Edgar Link unprocessable
nvcr-20210630_def.xml Edgar Link unprocessable
nvcr-20210630_g1.jpg Edgar Link pending
nvcr-20210630_htm.xml Edgar Link completed
nvcr-20210630_lab.xml Edgar Link unprocessable
nvcr-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending